National Vision (EYE) Competitors $24.73 +1.40 (+6.00%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$24.17 -0.56 (-2.28%) As of 07/8/2025 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EYE vs. NVST, GKOS, IRTC, NARI, TMDX, BLCO, SLNO, INSP, PRCT, and LIVNShould you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Envista (NVST), Glaukos (GKOS), iRhythm Technologies (IRTC), Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry. National Vision vs. Its Competitors Envista Glaukos iRhythm Technologies Inari Medical TransMedics Group Bausch + Lomb Soleno Therapeutics Inspire Medical Systems PROCEPT BioRobotics LivaNova National Vision (NASDAQ:EYE) and Envista (NYSE:NVST) are both medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, media sentiment, profitability and risk. Do analysts rate EYE or NVST? National Vision currently has a consensus price target of $22.10, indicating a potential downside of 10.63%. Envista has a consensus price target of $20.23, indicating a potential upside of 0.40%. Given Envista's higher possible upside, analysts plainly believe Envista is more favorable than National Vision.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National Vision 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56Envista 1 Sell rating(s) 9 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.33 Is EYE or NVST more profitable? National Vision has a net margin of -1.40% compared to Envista's net margin of -44.90%. Envista's return on equity of 4.07% beat National Vision's return on equity.Company Net Margins Return on Equity Return on Assets National Vision-1.40% 3.44% 1.40% Envista -44.90%4.07%2.25% Does the media favor EYE or NVST? In the previous week, National Vision had 1 more articles in the media than Envista. MarketBeat recorded 7 mentions for National Vision and 6 mentions for Envista. Envista's average media sentiment score of 0.86 beat National Vision's score of 0.70 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Vision 4 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Envista 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, EYE or NVST? National Vision has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, Envista has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500. Which has better earnings & valuation, EYE or NVST? National Vision has higher earnings, but lower revenue than Envista. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational Vision$1.82B1.07-$28.50M-$0.33-74.94Envista$2.51B1.36-$1.12B-$6.53-3.09 SummaryEnvista beats National Vision on 8 of the 15 factors compared between the two stocks. Get National Vision News Delivered to You Automatically Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EYE vs. The Competition Export to ExcelMetricNational VisionCONS PD IndustryStaples SectorNASDAQ ExchangeMarket Cap$1.84B$33.75B$16.33B$8.95BDividend YieldN/A2.71%3.14%4.06%P/E Ratio-74.9432.2619.9220.10Price / Sales1.071.8656.95120.29Price / Cash14.2616.2714.6957.86Price / Book2.388.816.145.56Net Income-$28.50M$1.19B$680.31M$248.40M7 Day Performance2.36%-0.58%-0.82%4.67%1 Month Performance17.71%1.01%-0.65%6.64%1 Year Performance100.24%37.04%7.52%21.31% National Vision Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EYENational Vision2.6205 of 5 stars$24.73+6.0%$22.10-10.6%+93.4%$1.84B$1.82B-74.9413,411Analyst ForecastGap UpNVSTEnvista3.8065 of 5 stars$19.58-0.5%$20.23+3.3%+22.8%$3.33B$2.51B-3.0012,300GKOSGlaukos4.556 of 5 stars$103.42+2.0%$134.67+30.2%-16.3%$5.80B$383.48M-43.64780Positive NewsIRTCiRhythm Technologies1.0446 of 5 stars$153.96-0.5%$138.60-10.0%+40.4%$4.94B$591.84M-49.032,000News CoverageNARIInari MedicalN/A$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800TMDXTransMedics Group1.5222 of 5 stars$134.01+1.9%$127.33-5.0%-16.4%$4.45B$441.54M98.54210BLCOBausch + Lomb3.1036 of 5 stars$13.03+5.1%$15.54+19.3%-8.2%$4.39B$4.79B-12.6513,500Analyst ForecastHigh Trading VolumeSLNOSoleno Therapeutics4.7235 of 5 stars$83.78+0.6%$107.10+27.8%+101.0%$4.20BN/A-18.1330INSPInspire Medical Systems4.8272 of 5 stars$129.28-2.4%$211.91+63.9%-1.7%$3.91B$802.80M59.581,246News CoveragePositive NewsPRCTPROCEPT BioRobotics2.6605 of 5 stars$57.60+1.2%$90.00+56.3%-9.8%$3.15B$224.50M-33.88430News CoverageAnalyst ForecastLIVNLivaNova3.2024 of 5 stars$45.02-1.6%$59.29+31.7%-9.6%$2.49B$1.25B-11.012,900Positive News Related Companies and Tools Related Companies NVST Alternatives GKOS Alternatives IRTC Alternatives NARI Alternatives TMDX Alternatives BLCO Alternatives SLNO Alternatives INSP Alternatives PRCT Alternatives LIVN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EYE) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Vision Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share National Vision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
